Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor.
Okuyama T, Shirakawa J, Tajima K, Ino Y, Vethe H, Togashi Y, Kyohara M, Inoue R, Miyashita D, Li J, Goto N, Ichikawa T, Yamasaki S, Ohnuma H, Takayanagi R, Kimura Y, Hirano H, Terauchi Y.
Okuyama T, et al. Among authors: shirakawa j.
Int J Mol Sci. 2020 Oct 22;21(21):7815. doi: 10.3390/ijms21217815.
Int J Mol Sci. 2020.
PMID: 33105604
Free PMC article.